Skip to Content

JSP 520 (Levothyroxine 150 mcg (0.15 mg))

Pill imprint JSP 520 has been identified as Levothyroxine sodium 150 mcg (0.15 mg).

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 150 mcg (0.15 mg) is not a controlled substance under the Controlled Substance Act (CSA).

Levothyroxine sodium 150 mcg (0.15 mg) JSP 520 Front
Levothyroxine sodium 150 mcg (0.15 mg) JSP 520 Back
Levothyroxine sodium 150 mcg (0.15 mg) JSP 520
Levothyroxine sodium 150 mcg (0.15 mg) JSP 520
Levothyroxine sodium 150 mcg (0.15 mg) JSP 520
Levothyroxine sodium
JSP 520
150 mcg (0.15 mg)
7.00 mm
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Lannett Company, Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
FD&C Blue No. 2
aluminum oxide

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00527-1377 Lannett Company, Inc.
00527-1377 Lannett Company, Inc.
66336-0801 Dispensing Solutions Inc. (repackager)
21695-0756 Rebel Distributors Corp (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.